It is known that the majority of TP53-mutant breast tumors are ERα-negative [77], and our analyses have revealed that ERα-negative tumors have reduced expression of MDM4 and MDM2 mRNA (Figure 1, panels E and F). This evidence concerns the gene TP53 and breast neoplasm.